Mississippi sues pharmaceutical company

Jul 25, 2006

Mississippi has filed a legal action against Eli Lilly and Co. alleging a plan to defraud the state of millions of dollars in Medicaid reimbursements.

The lawsuit involves the "off-label" uses of the anti-psychotic drug Zyprexa, the Jackson (Miss.) Clarion Ledger reported.

The suit alleges representatives of Eli Lilly persuaded Mississippi doctors to prescribe the drug to patients suffering from conditions such as anxiety, mood swings and disturbed sleep when the drug is only approved to treat bipolar disorder and schizophrenia.

Tim Balducci, Mississippi special assistant attorney general, told the Clarion Ledger Eli Lilly targeted Mississippi because the state's Medicaid system cannot determine when a medication is prescribed for non-approved uses.

The Indianapolis-based Eli Lilly has 30 days to respond to the suit.

Copyright 2006 by United Press International

Explore further: Slow walking speed and memory complaints can predict dementia (w/ Video)

add to favorites email to friend print save as pdf

Related Stories

Apple's fiscal 3Q earnings top analyst forecasts

4 hours ago

Apple's growth prospects are looking brighter as anticipation builds for the upcoming release of the next iPhone, a model that is expected to cater to consumers yearning for a bigger screen.

Recommended for you

Study recommends inmate immunity test

2 hours ago

(AP)—Federal experts are recommending that California test inmates for immunity to a sometimes fatal soil-borne fungus before incarcerating them at two Central Valley state prisons where the disease has killed nearly three ...

User comments : 0